ArticlePsychiatry research2026
Speech as an objective measure of psychomotor dysfunction in major depressive disorder: validation from non-speech motor measures.
Article in Psychiatry research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Psychomotor dysfunction, which can manifest as slowing (psychomotor retardation; PmR) and jerkiness or restlessness (psychomotor agitation; PmA) often occurs in individuals with major depressive disorder (MDD). As psychomotor dysfunction predicts a worse treatment response, accurately measuring and tracking PmR and PmA may improve outcomes. Traditionally, psychomotor dysfunction has been assessed using self-report or observer-based methods, which are often insensitive to subtle but potentially relevant movement abnormalities. Instrumental probes often require specialized equipment. Speech presents a promising option as it requires a significant motor component and is easy to collect. This study serves as a preliminary test of the association between speech indicators of PmR and PmA and manual motor tasks (handwriting velocity and force variability). Participants with current MDD (n = 36) and remitted MDD (n = 78) completed a diadochokinetic speech task, quickly repeating syllables in a sequence ("pataka" and "katapa"), as well as a test of handwriting velocity while drawing loops (PmR) and a test of variability in force applied to a transducer (PmA). Velocity of speech production and speech rate variability were automatically measured. For current MDD individuals, speech velocity was positively associated with the manual PmR measure (t(29) = 2.59, p < 0.05), and speech rate variability was positively associated with the manual PmA measure (t(33) = 2.952, p < 0.01). Effects were not significant for remitted MDD individuals, suggesting that this method may detect PmR/PmA only in those with acute depressive symptoms. These results suggest that diadochokinetic speech is a promising, objective measure of psychomotor dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.